New search tool to help myeloma patients find clinical trials

Woman using mobile phone

Myeloma Patients Europe (MPE) has launched a new online tool to facilitate the search of clinical trials in myeloma.

The Myeloma and AL Amyloidosis European Clinical Trial Navigator is designed to help patients find clinical trials for myeloma, monoclonal gammopathy of undetermined significance (MGUS), smouldering multiple myeloma (SMM) and amyloidosis (AL) in Europe.

Solène Clavreul, Head of Medical Education and Scientific Engagement at MPE, said: “Many patients are not aware of clinical trial options. The Navigator will be useful to help myeloma and AL amyloidosis patients find clinical trials in their own country and in Europe. It will also help patient advocates to analyse the clinical trial landscape in Europe and advocate for better access to clinical trials in their country.”

The Navigator offers an easy way to search for clinical trials by selecting only the relevant condition. The platform allows an advanced search to select characteristics such as the study phase, recruitment status, type of medicine or results availability, among others.

The Navigator also provides the option of locating the selected clinical trials in a map for the user to know in which country and which centre the clinical trials are taking place.

It is currently available in English but will be available in more European languages in the future.

Dr Claudio Cerchione, Haematology Unit, Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” (IRST IRCCS), Italy, and member of MPE’s Medical Advisory Committee, said: “The Navigator is a great opportunity for both patients and caregivers and myeloma physicians and researchers. It can help to look for the best therapeutic opportunity in the current setting of disease and to help centres to refer patients.”

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free